F-group (family)

805.1.1.1 5_nucleotid_C

Open in classification tree →Pfam PF02872 →

Ligands and drugs

172

Member domains

with ligand contacts (≤ 4 Å)

55.2% of members

with DrugDomain annotations

49.4% of members

with a DrugBank compound

30.2% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 805.1.1.1 belongs to X-group 805 5'-nucleotidase (syn. UDP-sugar hydrolase), C-terminal domain, which has 10 proteins with classified ligands. View its chemical profile →

DrugBank compounds

DrugBank	PDB ligand	Name	Domains
DB03148	A12	Adenosine 5'-methylenediphosphate	8
DB00640	ADN	Adenosine	5
DB00141	NAG	N-Acetylglucosamine	4
DB03900	TBU	tert-butanol	3
DB02745	URI	Uridine	2
DB00131	AMP	Adenosine phosphate	1
DB00140	RBF	Riboflavin	1
DB00171	ATP	ATP	1
DB00201	CFF	Caffeine	1
DB00806	—	Pentoxifylline	1
DB01972	G	Guanosine-5'-Monophosphate	1
DB02097	CTN	Cytidine	1
DB03403	C	Cytidine-5'-Monophosphate	1
DB03407	4NC	4-Nitrocatechol	1
DB03554	IUR	5-Iodouracil	1
DB03685	U	Uridine monophosphate	1
DB03798	DCM	2'-Deoxycytidine-5'-Monophosphate	1
DB04485	THM	Thymidine	1
DB04566	IMP	Inosinic Acid	1
DB08217	MTN	S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate	1

Most frequently bound compounds

PDB ligand	Name	Domains in contact
ZNmetal	ZINC ION	29
A12	PHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER	7
MNmetal	MANGANESE (II) ION	7
ADN	ADENOSINE	5
VPD	6-chloro-N-cyclopentyl-1-{5-O-[(2R)-1-hydroxy-3-methoxy-2-phosphonopropan-2-yl]-beta-D-ribofuranosyl}-1H-pyrazolo[3,4-d]pyrimidin-4-amine	4
TBU	TERTIARY-BUTYL ALCOHOL	3
A1IT6	[[(2~{R},3~{S},4~{R},5~{R})-5-[2-chloranyl-6-[[4-[1-(2-fluoranylethyl)-1,2,3-triazol-4-yl]phenyl]methyl-propyl-amino]purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid	2
A1IZZ	[[(2~{R},3~{S},4~{R},5~{R})-5-[2-chloranyl-6-[(phenylmethyl)-propyl-amino]purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid	2
A1JCF	[[(2~{R},3~{S},4~{R},5~{R})-5-[5-chloranyl-7-[[(1~{S})-1~{H}-inden-1-yl]-methyl-amino]-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid	2
A1JCG	[(2~{R})-2-[[(2~{R},3~{S},4~{R},5~{R})-5-[6-chloranyl-4-(cyclopentylamino)pyrazolo[3,4-d]pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy]-1-oxidanyl-3-(2~{H}-1,2,3,4-tetrazol-5-yl)propan-2-yl]phosphonic acid	2
A1JCH	[(2~{S})-2-[[(2~{R},3~{S},4~{R},5~{R})-5-[6-chloranyl-4-(cyclopentylamino)pyrazolo[3,4-d]pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy]-1-oxidanyl-3-(1~{H}-1,2,3,4-tetrazol-5-ylmethoxy)propan-2-yl]phosphonic acid	2
BOI	[[(2~{R},3~{S},4~{R},5~{R})-5-[(4~{E})-4-[(4-chlorophenyl)methoxyimino]-3-methyl-2-oxidanylidene-pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid	2
BW0	[[(2~{R},3~{S},4~{R},5~{R})-5-[(4~{E})-4-[(4-methoxycarbonylphenyl)methoxyimino]-3-methyl-2-oxidanylidene-pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid	2
NAG	2-acetamido-2-deoxy-beta-D-glucopyranose	2
O1H	4-[[5-[7-chloranyl-3-(1~{H}-indazol-6-yl)benzotriazol-5-yl]pyrazol-1-yl]methyl]benzenecarbonitrile	2
O1Q	4-chloranyl-1-(1~{H}-indazol-6-yl)-6-[2-(3-methylphenyl)pyrazol-3-yl]benzotriazole	2
OO2	[(2~{R},3~{S},4~{R},5~{R})-5-[2-chloranyl-6-(cyclopentylamino)purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxymethylphosphonic acid	2
OO5	[(2~{R},3~{S},4~{R},5~{R})-5-[6-chloranyl-4-(cyclopentylamino)pyrazolo[3,4-d]pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxymethylphosphonic acid	2
URI	URIDINE	2
VPG	6-chloro-N-[(2-chlorophenyl)methyl]-1-[5-O-(phosphonomethyl)-beta-D-ribofuranosyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine	2